About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNANCT01052376

Endomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal Cancer

The principle objective of this study is to validate confocal endomicroscopy (CEM) in a national, multicenter study, in terms of its ability to diagnose neoplastic lesions in vivo, in two groups of pa...

Lead sponsor: Nantes University Hospital•6 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Nantes University Hospital

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•For IBD: Clinically and histologically proven UC and Crohn's disease involving at least 30% of colon, with disease duration over 8 years for pancolitis or over 15 years for left colitis
•For FAP: patients at least 2 years after colectomy, with either rectal stump or ileal pouch
•Obtained signed informed consent

Exclusion Criteria

•\- For IBD: Active disease (only for cohort I a) : For UC: Colitis Activity index \>= 8, Truelove and Witt's activity index: moderate or severe For CD: CDAI: \> 150
•Known intraepithelial neoplasia or colorectal cancer or any other malignancy
•Coagulopathy
•Prothrombin time \< 50% of control
•Platelet blood count \< 70 000/mm²
•Impaired renal function (creatinine \> 1.2 mg/dl)
•Pregnancy or breast-feeding
•Known allergy to indigo-carmin or fluorescein

Related studies

Microbial and Environmental Factors Associated With Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)

NCT06614738 · Familial Adenomatous Polyposis

Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)

NCT06641310 · Familial Adenomatous Polyposis

Familial Investigations of Childhood Cancer Predisposition

NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more

RECRUITINGPhase 3

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

NCT06950385 · Familial Adenomatous Polyposis (FAP)

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

NCT07245394 · Inflammatory Bowel Disease (IBD), Crohn Disease (CD), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 23, 2012Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment73

Start dateDec 2008

Last updatedMay 23, 2012

Condition

Inflammatory Bowel Disease (IBD)Familial Adenomatous Polyposis

Locations shown

CHU de Lille

Lille

Hôpital Saint Philibert

Lomme

Institut Paoli Calmettes

Marseille

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2012Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions